Glycan-Mediated Immune Regulation
Advancing a pipeline of novel therapeutics to treat cancer and inflammatory disease

Glycan-Mediated Immune Regulation

From discovery to breakthrough

Targeting glycan-sensing checkpoints to unleash both innate and adaptive immune response to cancer

Our path to patient impact

Developing novel, first-in-class medicines to transform the treatment of cancer

Our team

We are driven to advance a completely new modality for cancer

Posters & Publications

Poster

HYDRA Platform Development to Investigate Siglec-engaging Tumor Immunosuppressive Glyco-codes

Society for Immunotherapy of Cancer’s (SITC) 34th Annual Meeting, November 9, 2019, Abstract #P118
Poster

Blockade of Siglec/Sialoglycan Axis Using EAGLE Technology to Potentiate Anticancer Immunity

Society for Immunotherapy of Cancer’s (SITC) 34th Annual Meeting, November 8, 2019, Abstract #P273

View all posters & publications